Haibo Wang
Corporate Officer/Principal presso HARPOON THERAPEUTICS, INC.
Profilo
Haibo Wang is a professional who currently holds the position of Senior Vice President-Business Development at Harpoon Therapeutics, Inc. He previously worked as Vice President-Business Development at Hummingbird Bioscience Pte Ltd.
Wang holds an MBA from Duke University, a graduate degree from The Johns Hopkins University, and an undergraduate degree from Tsinghua University.
Posizioni attive di Haibo Wang
| Società | Posizione | Inizio |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2023 |
Precedenti posizioni note di Haibo Wang
| Società | Posizione | Fine |
|---|---|---|
Hummingbird Bioscience Pte Ltd.
 Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore. | Corporate Officer/Principal | - |
Formazione di Haibo Wang
| The Johns Hopkins University | Graduate Degree |
| Tsinghua University | Undergraduate Degree |
| Duke University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
Hummingbird Bioscience Pte Ltd.
Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore. | Commercial Services |
- Borsa valori
- Insiders
- Haibo Wang
